Navila Talib Chaudhry, Jonathan Benn, Bryony Dean Franklin
{"title":"Secondary uses of electronic prescribing and pharmacy data in UK hospital care: a national survey.","authors":"Navila Talib Chaudhry, Jonathan Benn, Bryony Dean Franklin","doi":"10.1136/bmjoq-2024-002754","DOIUrl":null,"url":null,"abstract":"<p><p>Electronic hospital pharmacy (EHP) systems are ubiquitous in today's hospitals, with many also implementing electronic prescribing (EP) systems; both contain a potential wealth of medication-related data to support quality improvement. The reasons for reuse and users of this data are generally unknown. Our objectives were to survey secondary use of data (SUD) from EHP and EP systems in UK hospitals, to identify users of and factors influencing SUD.A national postal survey was sent out to all hospital chief pharmacists with pre-notifications and follow-up reminders. Descriptive statistical analysis was performed.Of 187 hospital organisations, 65 (35%) responded. All had EHP systems (for ≥20 years) and all reused data; 50 (77%) had EP systems (established 1-10 years) but only 40 (80%) reused data. Reported facilitators for SUD included medication safety, providing feedback, benchmarking, saving time and patient experience. The purposes of SUD included audits, quality improvement, risk management and general medication-related reporting. Earlier introduction of SUD could provide an opportunity to heighten local improvement initiatives.Data from EHP systems is reused for multiple purposes. Evaluating SUD and sharing experiences could provide richer insight into potential SUD and barriers/factors to consider when implementing or upgrading EP/EHP systems.</p>","PeriodicalId":9052,"journal":{"name":"BMJ Open Quality","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11184197/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Quality","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjoq-2024-002754","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Electronic hospital pharmacy (EHP) systems are ubiquitous in today's hospitals, with many also implementing electronic prescribing (EP) systems; both contain a potential wealth of medication-related data to support quality improvement. The reasons for reuse and users of this data are generally unknown. Our objectives were to survey secondary use of data (SUD) from EHP and EP systems in UK hospitals, to identify users of and factors influencing SUD.A national postal survey was sent out to all hospital chief pharmacists with pre-notifications and follow-up reminders. Descriptive statistical analysis was performed.Of 187 hospital organisations, 65 (35%) responded. All had EHP systems (for ≥20 years) and all reused data; 50 (77%) had EP systems (established 1-10 years) but only 40 (80%) reused data. Reported facilitators for SUD included medication safety, providing feedback, benchmarking, saving time and patient experience. The purposes of SUD included audits, quality improvement, risk management and general medication-related reporting. Earlier introduction of SUD could provide an opportunity to heighten local improvement initiatives.Data from EHP systems is reused for multiple purposes. Evaluating SUD and sharing experiences could provide richer insight into potential SUD and barriers/factors to consider when implementing or upgrading EP/EHP systems.
电子医院药房(EHP)系统在当今医院中无处不在,许多医院还采用了电子处方(EP)系统;这两种系统都包含大量潜在的药物相关数据,可为质量改进提供支持。这些数据被重复使用的原因和用户通常不为人知。我们的目标是调查英国医院对 EHP 和 EP 系统数据的二次使用情况(SUD),以确定 SUD 的使用者和影响因素。在 187 家医院机构中,有 65 家(35%)做出了回应。所有医院都拥有 EHP 系统(使用时间≥20 年),并且都重复使用了数据;50 家医院(77%)拥有 EP 系统(使用时间 1-10 年),但只有 40 家医院(80%)重复使用了数据。据报告,促进 SUD 的因素包括用药安全、提供反馈、制定基准、节省时间和患者体验。使用 SUD 的目的包括审计、质量改进、风险管理和一般药物相关报告。较早引入 SUD 可以为加强地方改进措施提供机会。对 SUD 进行评估并分享经验,可以让人们更深入地了解潜在的 SUD 以及在实施或升级 EP/EHP 系统时需要考虑的障碍/因素。